Clinical Trials Browser

Phase 1/2 × OTHER × tipiracil × Clear all

NCT05508737 2025-07-11

Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer

Phase 1/2 Active not recruiting

Gastrointestinal

Gastric and Gastroesophageal Junction Adenocarcinoma

NCT05201352 2025-05-30

TASKIN

Phase 1/2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06202001 2024-04-02

Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms